Final report: Phase I trial of desmethylmisonidazole (DMM) - an hypoxic cell sensitizer

T. H. Wasserman, C. N. Coleman, R. Urtasun

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Final report: Phase I trial of desmethylmisonidazole (DMM) - an hypoxic cell sensitizer'. Together they form a unique fingerprint.